Redeye states that sales were lower than estimated and that weak profitability led to adjusted EBIT below estimates. Enea states that it will find it challenging to reach an EBIT margin above 20% in 2022. Redeye will lower its estimates on both sales and margin. As a result, Redeye's valuation will be lowered by around 10%.